Mark Gardner

1.8k citations
34 papers · 1.6k · h-index 18

Impact in

    • Pharmacogenetics and Drug Metabolism
    • Antibiotics Pharmacokinetics and Efficacy
  • Oncology top 10%
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Pharmacogenetics and Drug Metabolism 15
    • Antibiotics Pharmacokinetics and Efficacy 2
    • Cancer Immunotherapy and Biomarkers 6

Mark Gardner

33 papers receiving 1.4k citations

Peers

Mark Gardner
Comparison fields: 5 of 88
  • Pharmacology 413
  • Oncology 297
  • Infectious Diseases 206
  • Pharmacology 145
  • Pharmaceutical Science 68
Replace Elaine Radwanski with:
Elaine Radwanski United States
Michael Seiberling Switzerland
Brigitte Roos Switzerland
Thomas L. Hunt United States
Rob ter Heine Netherlands
Guy Montay France
HUGH R. WILTSHIRE United Kingdom
Robert R. LaBadie United States
Vijay K. Batra United States
Dong‐Seok Yim South Korea
Mark Gardner relative to Elaine Radwanski United States Elaine Radwanski's profile →
Citations per field
00.5×2×2.8×
Elaine Radwanski · 1×
Citations per year

Countries citing papers authored by Mark Gardner

Since Specialization
Citations

This map shows the geographic impact of Mark Gardner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Gardner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Gardner more than expected).

Fields of papers citing papers by Mark Gardner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Gardner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Gardner. The network helps show where Mark Gardner may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Gardner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Gardner Line = papers co-authored together Mark Gardner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1979213
2 1991149
3 1978146
4 2018124
5 1991100
6 199196
7 201978
8 201977
9 201766
10 199160
11 201456
12 199346
13 199543
14 201638
15 198831
16 199729
17 200624
18 201818
19 201918
20 200617

About Mark Gardner

Mark Gardner is a scholar working on Pharmacology, Oncology, Endocrinology, Diabetes and Metabolism, Pharmacology and Pharmaceutical Science, having authored 34 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (15 papers), Cancer Immunotherapy and Biomarkers (6 papers), Menopause: Health Impacts and Treatments (4 papers), Drug Solubulity and Delivery Systems (2 papers), Antifungal resistance and susceptibility (2 papers), Cancer Genomics and Diagnostics (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Pharmacology (413 citations), Oncology (297 citations), Infectious Diseases (206 citations), Pharmacology (145 citations) and Pharmaceutical Science (68 citations). Mark Gardner has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Jerome J. Schentag, William J. Jusko, Donald M. Hilligoss, Antoinette Mangione, John W. Vance, Jeffrey R. Koup, Robert A. Blum, Anthony M. Yurchak, John H. Clark and John H. Wilton. Their work appears in journals such as The Journal of Clinical Pharmacology, Journal for ImmunoTherapy of Cancer, Clinical Pharmacology & Therapeutics, Oncotarget and Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact